Today’s Solutions: January 27, 2022

Methotrexate is a commonly used chemotherapy drug employed to treat osteosarcoma, a bone cancer. Unfortunately, one side effect of traditional chemotherapy is the potential to harm perfectly healthy cells in the process of destroying cancerous ones. Researchers from Washington University in St. Louis think they are on their way to a solution to this problem with a new bone cancer treatment that uses two drugs to target the energy sources of cancerous tumors. 

The newly-developed therapy starts with a drug called NCT-503, which is part of a category of drugs that offers metabolic therapies for cancer. These experimental therapies go after the chemical reactions that allow cancerous cells to sustain themselves. Specifically, NCT-503 inhibits the production of amino acid serine, which allows cancerous cells to multiply, essentially stopping the tumor from growing. 

Once the cells stop multiplying, they usually turn to alternative energy sources by burning metabolic build-up using a molecule called mTORC1. This is where the second drug comes in. A mTORC1 inhibitor blocks this function, denying the cells of energy completely so they eventually die off. 

In experiments, the two-drug method has been successful in slowing the growth of cancerous tumors. Although the method is not yet ready for human trials, it does offer the potential for chemotherapy-free cancer treatments in the future. Even if the two-drug method cannot eliminate cancer cells altogether, it could vastly reduce the concentration and frequency of chemotherapy treatments for less detrimental effects on healthy cells and less invasive treatments for patients. 

Solutions News Source Print this article
More of Today's Solutions

Cooling bamboo system is a green alternative to air conditioning

The number of sweltering days affecting people each year in Vietnam has grown significantly in recent years as a result of climate change. Using air conditioning may help reduce people’s exposure to life-threatening hot temperatures, ... Read More

Weird species of worm named after Godzilla’s enemy

We love sharing the uncovering of the vast biodiversity of our world with our readers. In 2020 alone, 503 new animal species were discovered. From the Popa langur monkey, to nine new snake species and ... Read More

Gene-therapy could treat leading cause of blindness

Throughout the past decade, it seems like science is getting closer to the reality of gene therapy. Here at The Optimist Daily, we’ve reported on a number of potential uses for the practice, including; curing ... Read More

Could electric rail vehicles be the future of freight?

According to the Environmental Protection Agency, medium- and heavy-duty trucks are responsible for 24 percent of the total greenhouse gas emissions spewed by the transportation industry in the US. A team of former SpaceX engineers ... Read More

Levitating ice leads to deeper understanding of energy

Believe it or not, scientists have been levitating water since the 18th century. The Leidenfrost effect was first described in 1751 by a German doctor and theologian, who named the phenomenon after himself. Using a ... Read More

Goldie the porcupine pufferfish is thriving after emergency dental work

Did you know that porcupine pufferfish teeth, which are known as beaks, never stop growing throughout the fish’s life? “They’re usually kept short naturally, as they’re worn down on their regular diet of hard-shelled foods,” ... Read More